Scienmag
FEBRUARY 20, 2022
An international collaborative research group consisting of members from 7 institutions has developed a method of determining which amphibious species (types of frog, newt and salamander) inhabit an area. They achieved this by amplifying extra-organismal DNA (environmental DNA) found in the water so that they could be analyzed. This DNA ends up in the water […].
JAMA Internal Medicine
FEBRUARY 20, 2022
This systematic review and meta-analysis of case studies and case reports assesses the risk of severe immediate allergic reactions to a second dose of SARS-CoV-2 mRNA vaccine among persons with immediate allergic reactions to their first vaccine dose.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Scienmag
FEBRUARY 20, 2022
Embargoed until 9 a.m. ET, Sunday Feb. 20, 2022 Vacation photos of zebras and whales that tourists post on social media may have a benefit they never expected: helping researchers track and gather information on endangered species. Scientists are using artificial intelligence (AI) to analyze photos of zebras, sharks and other animals to identify […].
Drug Patent Watch
FEBRUARY 20, 2022
Annual Drug Patent Expirations for METROGEL Metrogel is a drug marketed by Galderma Labs Lp and Bausch and is included in three NDAs. It is available from two suppliers. There…. The post New patent expiration for Galderma Labs drug METROGEL appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
FEBRUARY 20, 2022
Imagine making some liquids mix that do not mix, then unmixing them. Credit: Flinders University Imagine making some liquids mix that do not mix, then unmixing them. In one of the grand challenges of science, a Flinders University device which previously ‘unboiled’ egg protein is now unravelling the mystery of incompatible fluids; a development that could enhance […].
Drug Patent Watch
FEBRUARY 20, 2022
Annual Drug Patent Expirations for OCALIVA Ocaliva is a drug marketed by Intercept Pharms Inc and is included in one NDA. It is available from one supplier. There are ten…. The post New patent expiration for Intercept Pharms drug OCALIVA appeared first on DrugPatentWatch - Make Better Decisions.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Roots Analysis
FEBRUARY 20, 2022
Over the last decade, one of the major challenges faced by pharmaceutical players across the globe is low drug solubility. In fact, it has been observed that around 40% of the pharmaceutical products approved by regulatory organizations exhibit poor bioavailability / solubility. Further, every year, poor bioavailability is one of the prime reasons that leads to failure in obtaining approval authorization.
Scienmag
FEBRUARY 20, 2022
A sufficient intake of vegetables is important for maintaining a balanced diet and avoiding a wide range of diseases. But might a diet rich in vegetables also lower the risk of cardiovascular disease (CVD)? Unfortunately, researchers from the Nuffield Department of Population Health at the University of Oxford, the Chinese University of Hong Kong, and […].
Drug Patent Watch
FEBRUARY 20, 2022
Roflumilast is the generic ingredient in two branded drugs marketed by Astrazeneca, Breckenridge, Hetero Labs Ltd Iii, Micro Labs, Mylan, Strides Pharma, and Torrent and, and is included in seven…. The post New tentative approval for Zydus Pharms drug roflumilast appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
FEBRUARY 20, 2022
The consequences of peace and armed conflict for deforestation depend on the location, reports a new publication in Frontiers in Environmental Science. Using Colombia as a case study, this work presents one of the most comprehensive studies to date comparing forest loss to drivers such as coca cultivation and cattle farming during periods of peace […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Drug Patent Watch
FEBRUARY 20, 2022
This chart shows the pharmaceutical companies with the most patents in Singapore. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Singapore? appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
FEBRUARY 20, 2022
We are surrounded by information and news throughout the day, and we possess easy access to technology which allows that information to spread very quickly. Computers and the world of digital media have greatly accelerated the rate of information exchange and expanded how much is shared, but fundamentally, disinformation is a human problem. With all […].
Scienmag
FEBRUARY 20, 2022
A science game involving simulated animal battles reached half a million middle and high school students in the United States in 2021. Through this game, the students learned fundamental science principles. Credit: Steve Filmer, Arizona State University A science game involving simulated animal battles reached half a million middle and high school students in the […].
Scienmag
FEBRUARY 20, 2022
Researching how parents and extended family – kin networks, care for children in current industrialized nations. How do care networks change and affect children with pressures in current society? Credit: Steve Filmer, Arizona State University Researching how parents and extended family – kin networks, care for children in current industrialized nations.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
108 
Let's personalize your content